We have successfully completed a number of partnership working projects with various NHS organisations across the country, with some project on-going. Find out more about these projects by reading the executive summaries.
Betsi Cadwaladr University Health Board Pharmacy & Medicines Management Clinical Programme Groups (CPG) Partnership Working Initiative
Download the partnership case study >
Each University Health Board in Wales has a statutory duty to develop a three year strategic plan.
Betsi Cadwaladr University Health Board is the largest health organisation in Wales, providing healthcare services to a population of around 676,000 people across the six counties of North Wales, as well as some parts of mid Wales, Cheshire and Shropshire. It employs around 16,100 staff and has a budget of around £1.2 billion.1
The financial and operational challenges of 2013/14, together with the introduction of more robust planning required new ways of working and new ways of thinking.
In order to ensure that the University Health Board’s strategic plan was robustly developed and successfully delivered, there was an additional need for the development of operational plans at a Clinical Programme Group (CPG) level.
To support the University Health Board’s three year strategic plan, the Pharmacy & Medicines Management CPG along with other CPGs within the organisation were charged for the first time with the development of their own strategies and plans.
The aim of this externally facilitated project was to support the CPG in the process of developing their one year operational plan and to begin to consider what was required to develop three year rolling strategic plans.
The objectives of the project were aligned to:
The facilitators led four dedicated sessions over the 13 months of the project
The CPG team were set a task of developing their plans based on; MUST DO IMPERATIVES ONLY
This challenged historical ways of working at both an individual and team level
The facilitators supported the team in:
The facilitators encouraged the CPG team to:
The facilitators consistently:
The project delivered more outcomes than were initially planned
Quantitative
Qualitative
Innovative ways of working moving forward
The approach;
For the Betsi Cadwaladr University Health Board:
For the Pharmacy and Medicines Management Clinical Programme Group
For the wider NHS, this approach
Teva UK
_______________________________________________________________________________
References
[1] http://www.wales.nhs.uk/sitesplus/861/page/40836, website last accessed 9/10/15
Teva UK Limited and NHS East Riding of Yorkshire Partnership Project Case Study
Download the project working case study >
This is a case study of how NHS East Riding of Yorkshire worked in a local partnership with the Teva Integrated Healthcare Manager and Teva UK Limited to address the issue of medicine wastage.
A report by the Department of Health estimates that unused medicines cost the NHS around £300 million every year, with an estimated £110 million worth of medicine returned to pharmacies, £90 million worth of unused prescriptions being stored in homes and £50 million worth of medicines disposed of by Care Homes.1
NHS East Riding of Yorkshire identified significant areas of medicines wastage in the local area, which if it was addressed successfully could save the NHS around £500,000 per annum.
The local PCT identified that the main population groups responsible for the over ordering of medicines are younger mothers and those over 60 years of age.
The objectives of this Be Medicine Aware campaign was to:
In order to achieve these outcomes, NHS East Riding of Yorkshire worked in partnership with Teva UK Limited as they provided:
Both the NHS and Teva UK Limited abided by the relevant regulatory bodies and guidance, including the ABPI Code of Conduct.
Benefits of the partnership
This project demonstrated a successful partnership approach to address a significant public health issue facing the local health economy.
This partnership project provided a high profile campaign that strengthened public relations between the NHS, Teva UK Limited and local patients.